| Literature DB >> 18510777 |
Donna B Mak1, Rochelle E Watkins.
Abstract
BACKGROUND: Routinely collected infectious disease surveillance data provide a valuable means to monitor the health of populations. Notifiable disease surveillance systems in Australia have consistently reported high levels of completeness for the demographic data fields of age and sex, but low levels of completeness for Aboriginality data. Significant amounts of missing data associated with case notifications can introduce bias in the estimation of disease rates by population subgroups. The aim of this analysis was to evaluate the use of data linkage to improve the accuracy of estimated notification rates for sexually transmitted infections (STIs) and blood borne viruses (BBVs) in Aboriginal and non-Aboriginal groups in Western Australia.Entities:
Mesh:
Year: 2008 PMID: 18510777 PMCID: PMC2429908 DOI: 10.1186/1472-6963-8-118
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Figure 1Summary of the process used to derive sensitive and specific indicators of Aboriginality using data linkage.
Aboriginality of STI† and BBV‡ notifications received in 2004 prior to data linkage, and the proportion of notifications with unknown Aboriginality following data linkage
| Pre-linkage | Post-linkage | |||
| Disease | Aboriginal n (%) | Non-Aboriginal n (%) | Unknown n (%) | Unknown n (%) |
| Chlamydia, n = 4329 | 1078 (25) | 1789 (41) | 1462 (34) | 402 (9.3) |
| Gonorrhoea, n = 1433 | 1085 (76) | 307 (21) | 41 (3) | 12 (0.8) |
| Syphilis, n = 206 | 137 (66) | 45 (22) | 24 (12) | 2 (1.0) |
| Donovanosis, n = 1 | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
| Hepatitis B, n = 435 | 61 (14) | 317 (72) | 57 (13) | 27 (6.2) |
| Hepatitis C, n = 1215 | 134 (11) | 706 (58) | 375 (31) | 76 (6.3) |
| Total, n = 7619 | 2496 (33) | 3164 (41) | 1959 (26) | 519 (6.8) |
† Sexually Transmitted Infections (STI)
‡ Blood borne virus (BBV) notifications, excluding HIV (Human Immunodeficiency virus)
Comparison of the Aboriginality of STI† and BBV‡ notifications received in 2004 prior to and following data linkage by estimation method
| Aboriginal n (%) | non-Aboriginal n (%) | |||||
| Disease | Pre-linkage | Sensitive | Specific | Pre-linkage | Sensitive | Specific |
| Chlamydia | 1078 (25) | 1161 (27) | 1127 (26) | 1789 (41) | 2800 (65) | 2766 (64) |
| Gonorrhoea | 1085 (76) | 1093 (76) | 1086 (76) | 307 (21) | 335 (23) | 328 (23) |
| Syphilis | 137 (66) | 138 (67) | 137 (67) | 45 (22) | 67 (33) | 66 (32) |
| Hepatitis B | 61 (14) | 64 (15) | 64 (15) | 317 (72) | 344 (79) | 344 (79) |
| Hepatitis C | 134 (11) | 153 (13) | 138 (11) | 706 (58) | 1001 (82) | 986 (81) |
| Total | 2496 (33) | 2610 (34) | 2553 (34) | 3164 (41) | 4547 (60) | 4490 (59) |
† Sexually Transmitted Infections (STI) excluding Donovanosis
‡ Blood borne virus (BBV) notifications, excluding HIV (Human Immunodeficiency virus)
Multivariate analysis of association between whether Aboriginality could be determined via data linkage and the independent variables, age, sex and disease
| Independent variables | p | Odds Ratio | 95% CI† |
| Age (years) | 0.41 | 1.00 | 0.99–1.02 |
| Sex (female) | <0.001 | 1.50 | 1.21–1.85 |
| Disease (reference: Hepatitis B) | <0.001 | - | - |
| Chlamydia | 0.005 | 2.23 | 1.27–3.93 |
| Gonorrhoea | 0.07 | 2.27 | 0.95–5.43 |
| Syphilis | 0.004 | 9.66 | 2.06–45.3 |
| Hepatitis C | <0.001 | 3.48 | 1.92–6.28 |
† Confidence Interval (CI)
Comparison of age-standardised notification rates (per 100,000 population) and rate ratios of STI† and BBV‡ notifications received in 2004 by Aboriginality prior to and following data linkage by estimation method
| Pre-linkage | Sensitive | Specific | |||||||
| Disease | ATSI | non-ATSI | RR (95% CI) | ATSI | non-ATSI | RR (95% CI) | ATSI | non-ATSI | RR (95% CI) |
| Chlamydia | 1501 | 105 | 14.4 (11.2–18.6) | 1608 | 165 | 9.9 (7.6–12.9) | 1561 | 163 | 9.7 (7.4–12.7) |
| Gonorrhoea | 1524 | 18.0 | 89.4 (51.0–157) | 1534 | 19.6 | 82.1 (49.7–136) | 1526 | 19.2 | 83.5 (49.4–141) |
| Syphilis | 313 | 2.6 | 105 (65.3–168) | 315 | 3.8 | 70.5 (44.4–112) | 313 | 3.8 | 71.2 (45.1–112) |
| Hepatitis B | 117 | 18.5 | 5.9 (4.3–8.0) | 122 | 20.1 | 5.7 (4.4–7.5) | 122 | 20.1 | 5.7 (4.4–7.5) |
| Hepatitis C | 232 | 41.1 | 6.1 (4.7–8.0) | 271 | 58.2 | 5.0 (4.0–6.3) | 240 | 57.4 | 4.6 (3.5–6.0) |
† Sexually Transmitted Infections (STI) excluding Donovanosis
‡ Blood borne virus (BBV) notifications, excluding HIV (Human Immunodeficiency virus)
ATSI: Aboriginal and Torres Strait Islander
RR: rate ratio estimate based on Poisson regression coefficients
CI: confidence interval